Dr. Pikarsky of the department of immunology and cancer research at the Institute for Medical Research Israel Canada (IMRIC) in the Faculty of Medicine was nominated for insights gained from his work in complex mouse models, into the development of human diseases. According to the Sir Zelman Cowen Universities Fund, "His work has yielded new understanding of the determinants of malignancy in testicular cancer; of the impact of inflammation on the progress of liver cancer and the regulation of liver regeneration, important in all conditions which damage liver function."
Prof. Ben-Yehuda of the department of microbiology and molecular genetics at the Institute for Medical Research Israel Canada (IMRIC) in the Faculty of Medicine was nominated for her contributions to our understanding of the biology of bacteria. Her discoveries, which include the demonstration of a previously unknown ‘nanotube’ form of communication between cells, are also fundamental for understanding the mechanisms of bacterial resistance to antibiotics. In a statement, the Sir Zelman Cowen Universities Fund said that "this gives her work great importance for the treatment of infections caused by the growing number of resistant bacteria."
This is the first time the award has been shared between two nominees. The prize committee noted the impressive contributions both scientists have made to our understanding of complex and difficult diseases – cancer, and antibiotic-resistant infections. 'Their discoveries are impressive examples of how well-targeted research can tackle serious medical challenges," said Prof. Jonathan Stone, managing trustee of the Fund.
Prize medals, crafted by renowned Melbourne sculptor, Michael Meszaros, and the cash award of $10,000 will be presented to the scientists at a ceremony to be held during the annual meeting of the Hebrew University board of Governors in June 2011.
The Sir Zelman Cowen Universities Fund Prize For Discovery in Medical Research was first awarded in 2006 and recognizes discovery in medical research, by researchers under 45 years of age, which makes a major contribution to the understanding or treatment of disease. The prize is awarded in alternate years at the University of Sydney and at the Hebrew University of Jerusalem. It is one of a number of Fund initiatives aiming to support medical research at the University of Sydney and the Hebrew University of Jerusalem and to promote cooperative work between the two institutions.For further information:
Rebecca Zeffert | Hebrew University of Jerusalem
Helmholtz International Fellow Award for Sarah Amalia Teichmann
20.01.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Scientist from Kiel University coordinates Million Euros Project in Inflammation Research
19.01.2017 | Christian-Albrechts-Universität zu Kiel
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences